Tijuana, MEXICO
Personal stories from real people who survived their disease … And how they did it!
Sunivera Immunotherapy™ combines a powerful, immunotherapeutic macrophage activating factor (MAF) with synergistic therapies and nutraceuticals that work together to modulate the innate and adaptive immune systems. This proprietary Hope4Cancer therapeutic protocol combines 25 years of research expertise at leading Japanese and U.S.-based research centers with Hope4Cancer’s clinical experience in natural cancer therapies
Roundtable Discussion: Sunivera Immunotherapy
The immune system keeps our body free of pathogens and stops any abnormal cell growth that could lead to cancer. One of the major hallmarks of cancer is its ability to turn off or avoid the immune system, which allows its uninterrupted growth. Sunivera brings light into the immune-depleted darkness of cancer.
The process replaces a cancer-depleted, natural immune system component, MAF, which is essential for the ability of the immune system to recognize and kill cancer cells.
Sunivera’s MAF component is based on three generations of product optimization at leading research centers in Japan.
Sunivera avoids the pitfalls of conventional immunotherapies. Sunivera DOES NOT:
MAF (Macrophage Activating Factor) is a naturally produced glycoprotein in cells obtained from the Vitamin D3-binding serum protein. MAF is responsible for activating immune system macrophages into a form that can recognize and kill cancer cells. However, cancer cells produce an enzyme, alpha-N-acetylgalactosaminidase (nagalase) that deglycosylates serum protein, consequently preventing its conversion into MAF.